ENST00000430471 Promotes Development and Metastasis of Colorectal Cancer by Regulating the Expression of YBX-1
Authors Zhu Z, Zhang X, Zhou Y, Cheng J, Xu Z
Received 25 May 2020
Accepted for publication 23 July 2020
Published 11 August 2020 Volume 2020:12 Pages 7189—7197
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Xueqiong Zhu
Zhenghai Zhu,* Xiaoxin Zhang,* Ying Zhou, Jie Cheng, Zipeng Xu
Department of General Surgery, Xishan People’s Hospital, Wuxi, Jiangsu 214000, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zipeng Xu Email email@example.com
Background Information: Colorectal cancer (CRC) is a common malignant tumor of the digestive system. Long non-coding (lnc) RNA ENST00000430471 has been reported to be involved in CRC development and metastasis because of its cancer-promoting ability. However, the detailed molecular mechanisms of ENST00000430471 in CRC remain largely unknown.
Methods: The cell proliferation assay and Xenograft experiment were performed to examine the proliferation rate of the tumor cells. Invasiveness and migration capability of the cells were evaluated using the invasion and wound healing assays, respectively. In addition, the RNA pull-down assay and subsequent mass spectrometry techniques were performed to identify the proteins interacting with ENST00000430471.
Results: Herein, small specific inhibiting (si) RNA-si0471#2 was used to silence ENST00000430471 in HCT116 and SW620 cell lines. This led to a significant reduction in cell proliferation, migration, and invasion. The RNA pull-down assay and mass spectrometry further revealed that ENST00000430471 interacted with several proteins such as the Y-box-binding protein 1 (YBX-1). On one hand, silencing of ENST00000430471 decreased the mRNA and protein expression levels of YBX-1. On the other hand, overexpression of YBX1 partially attenuated the suppression of cell proliferation, invasion, and migration induced by ENST00000430471 silencing.
Conclusion: Silencing of ENST00000430471 inhibits proliferation, migration, and invasion of CRC cells by regulating YBX-1 expression. These results provide baseline information that is essential in the identification of effective therapeutic targets for CRC therapy.
Keywords: lncRNA, ENST00000430471, progress, colorectal cancer, YBX-1
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]